# Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma

> **NCT03119883** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 35 (actual)

## Conditions studied

- Monoclonal Gammopathy of Undetermined Significance
- Plasma Cell Myeloma

## Interventions

- **OTHER:** 5-Carbon C 13-labeled Glutamine
- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Uniformly-labeled [13C]glucose

## Key facts

- **NCT ID:** NCT03119883
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-02
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2024-08-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03119883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03119883, "Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03119883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*